Lv67
2410 积分 2024-06-18 加入
Property-based optimisation of PROTACs
1天前
已完结
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
3天前
已完结
Hydrogen Bonding, Hydrophobic Interactions, and Failure of the Rigid Receptor Hypothesis
4天前
已完结
Whatever happened to cassette-dosing pharmacokinetics?
4天前
已完结
The Affinity Advantage
18天前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
21天前
已完结
Keratinocytes: new perspectives in inflammatory skin diseases
1个月前
已完结
Inhibitors supercharge kinase turnover through native proteolytic circuits
1个月前
已完结
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
2个月前
已完结
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
2个月前
已完结
皖公网安备34019202002308
